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Abstrect
Background: To understand whether TLR-4-linked NF-kB activation negatively correlates with lipid peroxidation in
colitic animal models, we caused colitis by the treatment with dextran sulfate sodium (DSS) or 2,4,6-
trinitrobenzenesulfonic acid (TNBS) to C3H/HeJ (TLR-4-defective) and C3H/HeN (wild type) mice, investigated
inflammatory markers, lipid peroxidation, proinflammatory cytokines and TLR-4-linked NF-B activation, in colon
and intestinal bacterial composition in vivo.
Methods: Orally administered DSS and intrarectally injected TNBS all caused severe inflammation, manifested by
shortened colons in both mice. These agents increased intestinal myeloperoxidase activity and the expression of
the proinflammatory cytokines, IL-1b, TNF-a and IL-6, in the colon.
Results: DSS and TNBS induced the protein expression of TLR-4 and activated transcription factor NF-B. However,
these colitic agents did not express TLR-4 in C3H/HeJ mice. Of proinflammatory cytokines, IL-1b was most potently
expressed in C3H/HeN mice. IL-1b potently induced NF-B activation in CaCo-2 cells, but did not induce TLR-4
expression. DSS and TNBS increased lipid peroxide (malondialdehyde) and 4-hydroxy-2-nonenal content in the
colon, but reduced glutathione content and superoxide dismutase and catalase activities. These colitic inducers
increased the number of Enterobacteriaceae grown in DHL agar plates in both mice, although the number of
anaerobes and bifidobacteria grown in GAM and BL agar plates was reduced. E. coli, K. pneumoniae and Proteus
mirabilis isolated in DHL agar plates increased lipid peroxidation in liposomes prepared by L-a-phosphatidylcholine,
but B. animalis and B. cholerium isolated from BL agar plates inhibited it.
Discussion: These findings suggest that DSS and TNBS may cause colitis by inducing lipid peroxidation and
enterobacterial proliferation, which may deteriorate the colitis by regulating proinflammatory cytokines via TLR-4-
linked NF-B activation pathway.
Background
Inflammatory bowel disease (IBD), including ulcerative
colitis and Crohn disease, are chronically relapsing dis-
orders of the intestine [1,2]. Its pathogenic mechanism
is assumed to be a dysregulation of the intestinal
immune response to intestinal environmental antigens,
such as intestinal microflora, and characterized by the
activation of lymphocytes, macrophages, enterocytes and
endothelial cells, which cause the production of inflam-
matory mediators, such as IL-1b,I L - 6a n dT N F - a [3,4].
Intestinal microflora may play an important role in initi-
ating and perpetuating colonic inflammation. Intestinal
bacterial endotoxins, such as lipopolysaccharides (LPS),
penetrate the epithelial barrier, either due to damage or
via paracellular pathways, in order to directly stimulate
the mucosal immune system [5]. Alternatively, it is also
possible that enteric endotoxins may interact at the api-
cal surface and induce responses in the intestinal epithe-
lial cells. These may result in the production of
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and other mediators, such as myeloperoxidase and reac-
tive oxygen species (ROS), causing the inflammatory
activation of the mucosal immune system via distinct
signaling pathways through Toll-like receptors (TLRs)
and/or cytokine receptors [6].
TLRs, which serve as a major link between the innate
and adaptive mucosal immune responses, act as trans-
membrane co-receptors with CD14 in the cellular
response to LPS [7]. Among this family of receptors,
TLR-4, which is linked in the activation of transcription
factor NF-B, may potentially serve as the main media-
tors of LPS signaling in the IBD [8]. The activation of
NF-B in mucosal macrophages is accompanied by an
increased capacity of these cells to produce and secrete
IL-1, IL-6 and TNF-a. These cytokines stimulate NF-kB
activation. IBD was not developed or progressed in germ-
free IL-10-deficient or IL-2 receptor-deficient animals as
well as in TLR-4 knockout animals, by colitic inducers,
dextran sulfate sodium (DSS) and 2,4,6-trinitrobenzene
sulfonic acid (TNBS) [9-11]. Therefore, the analysis of
TLR-linked NF-B activation, proinflammatory cytokine
expression patterns and intestinal gram-negative bacterial
quantity in IBD experimental animals could serve as a
helpful tool to characterize intestinal inflammation.
Reactive oxygen species (ROS), such as peroxide
anion, hydrogen peroxide, and hypochlorous acid, may
be involved in the pathogenesis of IBD. The colitic indu-
cers, DSS and TNBS, increase malondialdehyde and 4-
hydroxy-2-nonenal (4-HNE) in the colons of both mice,
but reduced the glutathione content and superoxide dis-
mutase and catalase activities, as previously reported
[12-14]. Treatment with superoxide dismutase signifi-
cantly ameliorates colitis [15].
In the present study, we conducted experimental coli-
tis by DSS or TNBS in C3H/HeN and C3H/HeJ mice
and investigated the relationship between colonic
inflammatory markers, such proinflammatory cytokines
and lipid peroxidation activation, in colon and colonic
gram-negative bacterial quantity.
Method
Materials
Dulbecco’s modified Eagle medium (DMEM), tetramethyl
benzidine, Griess reagent, DSS, hexadecyl trimethyl
ammonium bromide, and radio-immunoprecipitation
assay (RIPA) lysis buffer were purchased from Sigma Co.
(St Louis, MO, USA). A protease inhibitor cocktail was
from Roche Applied Science (Mannheim, Germany).
ELISA Kits were obtained from Pierce Biotechnology,
Inc., (Rockford, IL, USA). Antibodies for of pp65 (phos-
pho-NF-B), p65 (NF-B), and b-actin were purchased
from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.)
and Cell signaling technology Inc. (Danvers, MS, U.S.A.),
respectively. Enhanced chemiluminescence (ECL) immu-
noblot system was obtained from Pierce Co. (Rockford,
IL, U.S.A.). 4-HNE was purchased from Cayman Chemi-
cal Co. (Ann Arbor, MI, U.S.A.).
Culture of CaCo-2 cells
The human colon cancer cell line Caco-2 (KCLB 30037,
Korean Cell Line Bank, Seoul, Korea) was cultured in
DMEM supplemented with 10% heat-inactivated FBS, 2
mM L-glutamine, 1% nonessential amino acids, and
antibiotics. SW-480 were cultured in Eagle’sM E Ms u p -
plemented with 10% FBS, 2 mM L-glutamine, and anti-
biotics [16]. Cells were cultured in a water-saturated
atmosphere of 95% air and 5% CO. For immunoblot
analysis of NF-B, TLR-4 and b-actin, 5 × 10
5 cells
were seeded into a six-well ti s s u ec u l t u r ep l a t e( 2m l /
well) and were incubated at 50 to 70% confluency (nor-
mally 1 to 2 days after seeding). The medium was then
removed, and the cells were incubated at various times
with or without IL-1b. Viability before and after plating
was >95% by trypan blue dye exclusion.
Liposome preparation and lipid peroxidation-inhibitory
activity assay
For the liposome preparation, L-a-phosphatidylcholine
(0.1 g, type XV-E from egg yolk) was dissolved in diethyl
ether (10 ml) and distilled water (0.6 ml) was added.
The mixture was sonicated with an ultrasonic disrupter
(Eyelar Co., Tokyo, Japan) and evaporated under
vacuum on ice. The resulting extract was suspended in
30 ml of 0.1 M N-(2-acetamido)-imidinodiacetic acid
(ADA) sodium buffer (pH 6.7), sonicated for 15 min on
ice, and centrifuged at 1,500 × g for min at 4°C. The
supernatant was used as the liposome suspension.
To assay the lipid peroxidation-inhibitory activity, the
liposomal suspension (0.1 ml) was incubated in 1.5 ml
of 50 mM sodium phosphate buffer (pH 6.7), 0.1 ml of
2 mM ferrous chloride, and 0.1 ml of 4 mM sodium
ascorbate for 2 h at 37°C in the presence or absence of
bacterial cells. Lipid peroxide in the reaction mixture
was quantified as thiobarbituric acid-reactive substances
(TBARS) as reported previously [17].
Animals
Male C3H/HeN and C3H/HeJ mice (24 - 28 g) were sup-
plied by Orient Experimental Animal Breeding Center
(Seoul, Korea). C3H/HeJ mice possess a missense muta-
tion in the TLR-4 gene, which leads to a single amino
acid change in the cytoplasmic portion of TLR-4, imped-
ing signal transduction and leading to a phenotype simi-
lar to that of TLR-4 knockout mice [18]. C3H/HeJ mice
are defective in TLR-4 signaling and in responding to
LPS [TLR-4
(LPS-d)]. All animals were housed in wire
cages at 20-22°C and 50 ± 10% humidity, fed standard
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water ad libitum. All procedures relating to animals and
their care conformed to the international guidelines
‘Principles of Laboratory Animals Care’ (NIH publication
no. 85-23 revised 1985 and Kyung Hee University 2006).
Preparation of experimental colitis
The colitic mice induced by DSS and TNBS were pre-
pared according to the methods of Dieleman et al. [19]
and Neurath et al. [20], respectively.
TNBS-and DSS-induced colitis in C3H/HeN and TLR-
4 knockout C3H/HeJ mice was prepared according to
the above protocols. These mice were anesthetized with
ether and then sacrificed on the 3
rd and 7
th day after
the administration of TNBS and DSS, respectively.
Physical appearance, consistency of feces, diarrhea, the
presence of gross blood in stool, and body weight were
monitored daily. Macroscopic assessment of the disease
grade was scored according to a previously reported
scoring system (0, no ulcer and no inflammation; 1,
ulceration and local hyperemia; 2, ulceration without
hyperemia; 3, ulceration and inflammation at one site
only; 4, two or more sites of ulceration and inflamma-
tion; 5, ulceration extending more than 2 cm [21], and
the colon tissue was then used for immunoblot and
enzyme-linked immunosorbent assay (ELISA) analysis.
For histopathological examination, a segment of colon
tissues was flash frozen in lipid nitrogen and kept at
-80°C for further analysis and another portion was fixed
in formalin. Formalin sections were stained with hema-
toxylin-eosin and evaluated by light microscopy for the
presence of lesions.
Assay of myeloperoxidase activity in colonic mucosa
The colons isolated from the mice were homogenized in
a solution containing 0.5% hexadecyl trimethyl ammo-
nium bromide dissolved in 10 mM potassium phosphate
buffer (pH 7.0), and then centrifuged for 30 min at
20,000 × g (4°C). An aliquot (50 μl) of the supernatant
was added to a reaction mixture consisting of 1.6 mM
tetramethyl benzidine and 0.1 mM H2O2, incubated at
37°C and then the absorbance obtained at 650 nm spec-
tophotometrically time-scanned. The myeloperoxidase
activity was defined as the quantity of enzyme degrading
1 μmol/ml of peroxide at 37°C, and expressed in unit/
mg protein [22]. The protein content was assayed by
Bradford’s method [23].
Assay of lipid peroxide (malondialdehyde), reduced
glutathione amount and superoxide dismutase and
catalase activities
Lipid peroxidation was estimated in colon homogenates
as described by Ohkawa et al. [24]. Briefly, a reaction
mixture containing 50 mM Tris-HCl buffer (pH 7.4), 500
μM tert-butyl hydroperoxide (BHP) (in ethanol) and 1
mM ferrous chloride was incubated with the samples at
37°C for 90 min. The reaction was terminated by adding
0.2 ml of 8% sodium dodecyl sulfate followed by 1.5 ml
of 20% acetic acid (pH 3.5). The amount of malondialde-
hyde formed during the incubation was assessed by add-
ing 1.5% thiobarbituric acid and then heating at 95°C for
45 min. After cooling, the samples were centrifuged, and
the absorbance of TBARS in the supernatant was mea-
sured at 532 nm. The levels of lipid peroxidation are
expressed in terms of nmol TBARS/90 min/mg protein.
The amount of reduced glutathione in the tissue
homogenate was estimated according to the method of
Paglia and Valentine [25]. Catalase and superoxide dis-
mutase activities were estimated according to the
method of Prakash et al. [26].
Analysis of HNE by HPLC
The colon (1 g) was suspended in 1 ml of lysis buffer,
homogenized, centrifuged at 13000 rpm for 20 min twice,
and the supernatant was analyzed for 4-HNE using HPLC
(Younglin high performance liquid chromatography sys-
tem): column, Develosil ODS-UG-5 (4.6 mm i.d. × 150
mm, 5.8 μm particle diameter); mobile phase, linear-gradi-
ent mixture of 10% acetonitrile and 90% acetonitrile for 0
- 20 min and 100% acetonitrile for 20 - 30 min; flow rate,
1 ml/min; and detection, UV at 230/233 nm.
Enzyme-linked immunosorbent assay (ELISA) and
immunoblot
For the ELISA of IL-1b and IL-6, colons were homoge-
nized in 1 ml ice-cold lysis buffer (Radio-immunoprecipi-
tation assay, RIPA) containing 1% a protease inhibitor
cocktail and 1% phosphatase inhibitor cocktail). The lysate
was centrifuged (15,000 × g, 4 C) for 15 min, and the
supernatant transferred to 96-well ELISA plates. IL-1b and
IL-6 concentrations were determined using commercial
ELISA kits (Pierce Biotechnology, Inc., Rockford, IL, USA).
For the immunoblot of pp65 (phospho-NF-B), p65
(NF-B ) ,C O X - 2 ,i N O S ,T L R - 4a n db-actin, the colon
tissue was carefully homogenized to obtain many viable
single cells, which were resuspended in 1 ml of RIPA
lysis buffer containing 1% a protease inhibitor cocktail
and 1% phosphatase inhibitor cocktail). After centrifuga-
tion, the supernatant was used for the immunoblot
assay. The total protein from the collected cells was sub-
jected to electrophoresis on an 8-10% sodium dodecyl
sulfate-polyacrylamide gel, and then transferred to a
nitrocellulose membrane. The expression levels of pp65
(phospho-NF-B), p65 (NF-B ) ,C O X - 2 ,i N O S ,T L R - 4
and b-actin were assayed using their corresponding anti-
bodies, according to a previously reported method [27].
Immunodetection was carried out using an enhanced
chemiluminescence detection kit.
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activity assay
Fresh mouse stools (0.5 g) from each group were col-
lected separately in sterilized plastic cups, carefully sus-
pended in 20-volumes of saline in a cooled tube and
centrifuged at 250 × g for 5 min. The supernatant was
then centrifuged at 10,000 × g for 20 min. The resulting
precipitates were used as the sources for the fecal
enzyme assays. All procedures were performed at 4°C.
Bacterial enzyme activity assays for b-glucuronidase
and hyaluronic acid degradation were performed accord-
ing to the method of Lee et al. [28].
Bacterial culture in mouse stools and their identification
Fresh mouse stools (0.5 g) from each group were col-
lected separately in sterilized plastic cups, carefully sus-
pended in 20-volumes of peptone water, diluted 10-fold
in a stepwise manner, and inoculated in agar plates of
Figure 1 DSS or TNBS affects body weight (A), colon length (B), macroscopic score (C) and intestinal myeloperoxidase activity (D) in
C3H/HeN and C3H/HeJ mice. A histopathological exam was performed by hematoxylin-eosin staining (E). The mice treated with DSS or TNBS
were sacrificed on the 7
th and 3
rd day, respectively: the white bar, normal group; and black bar, DSS or TNBS-treated group. The values of
enzyme activities indicate the mean ± S.D. (n = 7). * Significantly different compared with normal group (p < 0.05).
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eral anaerobic medium (BL GAM, Nissui Pharm. Co.
Ltd) and hydrogen sulfate lactose medium (DHL, Eiken
Chem. Co., Ltd). DHL agar plates were cultured anaero-
bically for 1 day at 37°C, and BL and GAM agar plates
were cultured aerobically for 3 days at 37°C.
The colonies grown in DHL agar media were identi-
fied by 16S rDNA gene sequencing [29]. Total DNA
extracted from the colonies was used as a template to
amplify the 16S rRNA gene with primers 27f (5’ -
AGAGTTTGATCCTGGCTCAG-3’) and 1525r (5’-
AAAGGAGGTGATCCAGCC-3’), and its sequence was
analyzed using BLAST search.
Bacterial strains and growth conditions
Five intestinal bacterial strains were used in this study:
Bifidobacterium animalis (B1) and Bifidobacterium cho-
lerium (B2) isolated from BL agar plates and Escherichi
coli (Ec), Klebsiella pneumoniae (Kp) and Proteus mir-
abilis (Pm) isolated for DHL agar plates.
Each bacterial strain was grown to an optical density
between 3 and 4 at 600 nm in GAM broth, collected by
centrifugation (10,000 × g for 30 min) and washed twice
with saline. The resulting pellet was used for lipid per-
oxidation-inhibitory activity assay.
Statistical analysis
All data are expressed as the mean ± standard deviation,
with statistical significance analyzed using one-way
ANOVA followed by a Student-Newman-Keuls test.
Results
To evaluate the relationship between TLR-4-linked
inflammatory reaction and intestinal gram-negative bac-
teria, colitis was induced by the oral administration of
DSS for 7 days and intrarectal injection of TNBS in C3H/
HeN and C3H/HeJ mice, and colitic markers were mea-
sured. All normal animals showed body weight gain, but
DSS and TNBS treatment reduced body weight gain.
These colitic inducers, DSS and TNBS, caused severe
inflammation, manifested by shortened, thickened, and
erythematous colons in both mice. In macroscopic histol-
ogy, these inducers showed massive bowel edema and
epithelial cell disruption by large ulcerations in both
mice (Fig. 1). Myeloperoxidase, an inflammatory marker,
was also potently increased in both mice. The colitic
inducers also induced lipid peroxide (malondialdehyde)
and 4-HNE levels in the colons of C3H/HeN and C3H/
HeJ mice, but reduced the glutathione content and
superoxide dismutase and catalase activities (Table 1).
Treatment with DSS or TNBS also increased levels of
the pro-inflammatory cytokines, IL-6 and TNF-a,i nt h e
colon of both mice (Fig. 2). IL-1b was significantly
increased in C3H/HeN mice, but not in C3H/HeJ mice.
The treatment with these colitic inducers potently
induced TLR-4 expression in C3H/HeN mice, and acti-
vated NF-B. However, the treatment with DSS and
TNBS in C3H/HeJ did not express TLR-4, although NF-
B was activated. IL-1b potently induced NF-kB in
CaCo-2 cells, but did not increase TLR-4 expression
(Fig 3).
When C3H/HeN and C3H/HeJ mice were treated with
DSS or TNBS, the number of anaerobes grown in GAM
agar plate and bifidobacteria in BL agar plate was signifi-
cantly reduced, but the number of colonies grown in
DHL medium, which is a selective medium for Entero-
bacteriaceae, was significantly increased (Table 2). Pro-
teus mirabilis, E. coli,a n dK. pneumoniae were mainly
detected in C3H/HeN mice. However, P. mirabilis was
detected in C3H/HeJ mice, although E. coli,a n dK. pneu-
moniae were detected. Among intestinal bacteria grown
in BL and DHL agar plates, bifidobacteria grown,
Table 1 Effect of colitic inducers, TNBS and DSS, on lipid peroxide (malondialdehyde, MDA), 4-hydroxy-2-nonenal (4-
HNE), and glutathione (GSH) contents and superoxide dismutase (SOD), and catalase activities in the colons of C3H/
HeN and C3H/HeJ mice
Colitic inducer Content Activity
MDA (μM/mg) 4-HNE (ng/ml) GSH (μg/ml) SOD (Unit/mg) Catalase (mol/min/mg)
C3H/HeN -
a 0.74 ± 0.51 0.86 ± 0.85 1.51 ± 1.14 3.76 ± 1.30 5.22 ± 1.33
DSS 5.60 ± 1.04
# 11.92 ± 7.01
# 4.53 ± 0.15
# 1.06 ± 0.13
# 0.19 ± 0.94
#
C3H/HeJ -
a 0.72 ± 0.56 2.52 ± 3.11 0.67 ± 0.38 5.21 ± 1.83 6.25 ± 1.21
DSS 5.39 ± 1.00
# 2.93 ± 2.26
# 4.57 ± 0.12
# 0.72 ± 0.17
# 0.60 ± 1.41
#
C3H/HeN -
a 0.99 ± 0.09 3.31 ± 0.15 4.92 ± 1.33 3.39 ± 0.34 7.53 ± 0.77
TNBS 5.11 ± 0.67
# 15.92 ± 4.03
# 2.19 ± 0.24
# 0.16 ± 0.04
# 1.49 ± 1.00
#
C3H/HeJ -
a 0.66 ± 0.06 1.53 ± 1.80 4.38 ± 0.93 3.64 ± 0.47 4.76 ± 0.65
TNBS 2.95 ± 0.94
# 3.57 ± 0.89
# 2.13 ± 0.25
# 0.50 ± 0.03
# 0.82 ± 0.65
#
The test agents were orally administered once every day for 3 days prior to TNBS treatment. The mice were anesthetized with ether and killed 3 days after TNBS
treatment.
a) Normal group treated with vehicle alone instead of colitic inducer.
All values are the mean ± S.D. (n = 10).
#Significantly different vs normal group in each column of C3H/HeN or C3H/HeJ mice (P < 0.05).
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expression and activates transcription factor NF-B in C3H/
HeN and C3H/HeJ mice. (A) Colitic inducers increased the protein
expression of IL-1b, IL-6 and TNF-a in the colon of mice. The mice
treated with DSS or TNBS were sacrificed on the 7
th and 3
rd day,
respectively: the white bar, normal group; and black bar, DSS or
TNBS-treated group. These cytokines were determined by ELISA
assays. The values of enzyme activities indicate the mean ± S.D. (n
= 7). * Significantly different in each cytokine of DSS or TNBS-
treated mice compared with normal group (p < 0.05). (B) Colitic
inducer increased TLR-4 expression (white bar) and activated NF-B
(black bar). These expressions were measured by immunoblot
analysis.
Figure 3 IL-1b activates transcription factor NF-Bi nC a C o - 2
cells (5 × 10
5 cells). The cells were treated with IL-1b (NOR (-),
vehicle alone; CON (+), 10 ng/ml IL-1b) for 90 min and then
immunoblot for NF-B (pp65), TLR-4 and b-actin was performed.
Table 2 Effect of colitic inducers, TNBS and DSS, on
number of anaerobes and Enterobacteriaceae in C3H/
HeN and C3H/HeJ mice
Mouse Colitic
inducer
Number of colonies grown in agar plate
GAM
(Anaerobes)
(×10
10)
BL
(Bifido)
(×10
8)
DHL (×10
6)
Ec Pm Kp
C3H/
HeN
-
a 3.3 ± 0.5 6.6 ± 0.5 0.9 ±
0.3
0.9 ±
0.3
0.5 ±
0.2
DSS 2.3 ± 0.7 3.9 ± 0.5
# 5.1 ±
2.0
#
2.8 ±
0.6
#
14.0 ±
2.5
#
C3H/
HeJ
-
a 1.0 ± 0.4 4.2 ± 0.3 0.9 ±
0.2
-
b 5.0 ±
0.9
DSS 1.6 ± 0.5 3.7 ± 1.1
# 4.7 ±
0.6
#
-
b 9.2 ±
0.9
#
C3H/
HeN
-
a 3.2 ± 0.7 5.9 ± 1.1 0.3 ±
0.04
0.9
0.1
0.7 0.1
TNBS 1.9 ± 0.8
# 0.5 ± 0.1
# 3.2 ±
0.3
#
1.8 ±
0.1
#
17.8 ±
2.0
#
C3H/
HeJ
-
a 1.7 ± 0.6 20.9 ± 2.1 3.5 ±
0.6
-
b 2.8 ±
0.2
TNBS 0.6 ± 0.1
# 7.0 ± 0.8
# 49.1 ±
4.7
#
-
b 31.8 ±
8.6
#
The test agents were orally administered for 3 days prior to TNBS treatment.
The fresh feces was plated in BL, GAM, and DHL agar plates and cultured
anaerobically (for BL and GAM agar plates) or aerobically (for DHL agar
plates). The colonies grown in DHL agar media were selected and identified
by 16S rDNA analysis. Bifido, bifidobacteria; Ec, Escherichia coli; Pm, Proteus
mirabilis; Kp, Klebsiella pneumonia.
a) Normal group treated with vehicle alone instead of colitic inducer.
b) Not detected.
All values are the mean ± S.D. (n = 10).
#Significantly different vs. normal
group in each column of C3H/HeN or C3H/HeJ mice (P < 0.05).
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inhibited lipid peroxidation in liposomes prepared with
L-a-phosphatidylcholine, but E. coli, K pneumonia and P.
mirabilis grown in DHL agar plates increased it (Fig. 4).
Discussion
IBD is a severe form of intestinal inflammation, the
pathogenesis of which remains to be clearly understood.
It is thought that the disease might be attributed to
complex mucosal immune responses to resident enteric
bacteria[30,31]. The innate immune system recognizes
the presence of specific bacterial antigens through pat-
tern recognition receptors [7,8].
TLR-4 is an extensive family of pattern recognition
receptors and compelling research has shown that LPS,
which is expressed specifically by all gram-negative bac-
teria, binds to TLR-4 [32,33]. The triggering of TLR-4
complex signaling by LPS results in a cascade of events
that leads to the secretion of proinflammatory mediators
from monocytes and dendritic cells, which leads ulti-
mately to the activation of an acquired immune
response. Signaling through the TLR-4 complex contri-
butes actively to the development of inflammation and
may help to maintain an ongoing inflammatory response
[34,35]. TLR-4 is potently expressed in intestinal epithe-
lial cells from the colons of patients with IBD [6] and
significantly up-regulated during DSS-induced colitis in
mice [7].
In the present study, DSS and TNBS caused loss of
body weight, and severe inflammation, manifested by
shortened, thickened and erythematous colons in both
C3H/HeN and C3H/HeJ mice. DSS and TNBS did not
only potently activate NF-B, but also induced the
expression of TLR-4 and proinflammatory cytokines IL-
1b,T N F - a and IL-6 in C3H/HeN mice, as previously
reported [36,37]. However, DSS and TNBS-induced
TNF-a and IL-1b expression less in C3H/HeJ mice than
C3H/HeN mice, although NF-B activation was potently
activated in both mice. DSSa n dT N B Sc a u s e dm o r e
severe colonic inflammationa n dc o l o ns h o r t e n i n gi n
C3H/HeN mice than C3H/HeJ mice. Treatment with
IL-1b in CaCo-2 cells potently activated NF-B, but did
not induce TLR-4 expression. These results suggest that
D S Sa n dT N B Sm a yi n d u c ec o l i t i sv i at h ee x p r e s s i o no f
IL-1b,I L - 6 ,a n dT N F - a,a n dt h a tI L - 1 b m a yb ed e p e n -
dent on TLR-4-linked NF-kB activation.
Intestinal bacterial endotoxins, such as gram-negative
lipopolysaccharides, activate TLR-4-linked NF-kB and
cause colitic inflammation [7,16,30]. To confirm the role
of intestinal bacteria in colitic inflammation, we mea-
sured colonic bacterial composition in DSS or TNBS-
treated mice. When C3H/HeN and C3H/HeJ mice were
treated with DSS or TNBS, the number of anaerobes
and bifidobacteria was significantly reduced, but the
number of colonies grown in DHL medium, which is a
selective medium for Enterobacteriaceae, was signifi-
cantly increased. Proteus mirabilis, E. coli and K. pneu-
moniae were mainly detected in C3H/HeN mice, and E.
coli and K. pneumoniae were detected in C3H/HeJ mice.
These gram-negative bacteria, Proteus mirabilis, E. coli
and K. pneumoniae, produces endotoxin, which activates
TLR-4-linked NF-kB. Treatment with DSS or TNBS
increased the number of gram-negative bacteria and
decreased the number of bifidobacteria and anaerobes.
DSS and TNBS caused more severe colitis in C3H/HeN
mice than in C3H/HeJ mice, which paralleled changes
in bacterial composition. Thus, treatment with DSS and
TNBS may increase the growth of gram-negative bac-
teria, produce LPS, and cause colitis via TLR-4-linked
NF-kB activation. However, DSS and TNBS caused coli-
t i si nC 3 H / H e Jm i c e ,w h i c hi sT L R - 4 - d e f e c t i v e ,a sw e l l
as in C3H/HeN mice. These results suggest that DSS
and TNBS may cause colitis via TLR-4-linked pathway
as well as other pathway(s), such as oxidative stresses.
Reactive oxygen species (ROS), such as peroxide anion,
hydrogen peroxide, and hypochlorous acid, may actually
be involved in the pathogenesis of IBD as treatment
with superoxide dismutase significantly ameliorates the
colitis [15]. DSS and TNBS increased malondialdehyde
and 4-HNE in the colons of both mice, but reduced the
glutathione content and superoxide dismutase and cata-
lase activities, as previously reported [12-14].
Figure 4 Intestinal bacteria increase lipid peroxidation in
liposomes prepared with L-a-phosphatidylcholine. Lipid
peroxide in liposome was estimated by thiobarbituric acid-reactive
substance assay. The intestinal bacteria previously cultured in GAM
broth were collected by centrifugation (10,000 × g for 30 min) and
washed twice with PBS. The resulting pellet was suspended in
phosphate-buffered saline: Ba, Bifidobacterium animalis; Bc,
Bifidobacterium cholerium; Ec, Escherichia coli; Lp, Klebsiella
pneumoniae; Pm, Proteus mirabilis. Bh indicates butylated hydroxyl-
anisole. Test agents [20 (white bar), and 50 mg/ml (black bar)] was
treated. All values are the mean ± S.D. (n = 3).
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Page 7 of 9Particularly, these colitic inducers dramatically increased
4-HNE levels in C3H/HeN, compared with those in
C3H/HeJ. These results suggest that DSS and TNBS
may cause colitis independently of TLR-4-linked NF-B
activation, and lipid peroxidation in colitis may be
induced by TLR-4-linked NF-B activation.
Enterobacteriaceae, E. coli, K. pneumoniae and P. mir-
abilis induced by the treatment with DSS or TNBS in
mice increased lipid peroxidation in liposomes prepared
by L-a-phosphatidylcholine, but Bifidobacteria inhibited
it. The results suggest that the colitic inducers, DSS and
TNBS, may induce ROS directly as well as indirectly via
the proliferation of Enterobacteriaceae. Based on these
findings, DSS or TNBS may cause colitis by lipid peroxi-
dation and enterobacterial proliferation, which may
deteriorate the colitis by regulating proinflammatory
cytokines via TLR-4-linked NF-B activation pathway.
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